Impact of Pharmacist Involvement in Early Identification and Enrollment in Patient Assistance Programs on CMV Outcomes in Transplantation (Q42202589)

18 October 2017

title

Impact of Pharmacist Involvement in Early Identification and Enrollment in Patient Assistance Programs on CMV Outcomes in Transplantation (English)

1 reference

18 October 2017

Jennifer S Byrns

1 reference

18 October 2017

Nicole W Pilch

series ordinal

1 reference

18 October 2017

David J Taber

series ordinal

1 reference

18 October 2017

publication date

8 August 2014

1 reference

Journal of Pharmacy Practice

18 October 2017

published in

1 reference

18 October 2017

1 reference

18 October 2017

1 reference

18 October 2017

page(s)

97-102

1 reference

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0897190014544788

Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190014544788

Can preemptive cytomegalovirus monitoring be as effective as universal prophylaxis when implemented as the standard of care in patients at moderate risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190014544788

Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190014544788

New developments in the management of cytomegalovirus infection after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190014544788

Prevention of cytomegalovirus disease in solid organ transplant patients: prophylactic versus preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190014544788

Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190014544788

Impact of obtaining medications from pharmaceutical company assistance programs on therapeutic goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190014544788

Effects of a medication assistance program with medication therapy management on the health of renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190014544788

21 January 2018

Identifiers

DOI

10.1177/0897190014544788

1 reference

18 October 2017

1 reference